EMEA-002684-PIP02-21
Key facts
Invented name |
Pyrukynd
|
Active substance |
Mitapivat
|
Therapeutic area |
Haematology-Hemostaseology
|
Decision number |
P/0150/2022
|
PIP number |
EMEA-002684-PIP02-21
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of thalassaemia
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Agios Netherlands B.V.
Email: medinfo@agios.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|